Condition
Hypoxic Ischemic Encephalopathy (HIE)
Total Trials
6
Recruiting
3
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 6 trials
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 3 (1)
Trial Status
Not Yet Recruiting3
Recruiting3
Clinical Trials (6)
Showing 6 of 6 trials
NCT07493096Recruiting
Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disorders
NCT06762795Not ApplicableRecruiting
The HIEnome Study: Genome Sequencing for Perinatal HIE
NCT02664831Recruiting
Immunoinflammatory Response in Post Cardiac Arrest Syndrome (PCAS)
NCT07024771Not Yet RecruitingPrimary
Severity of Hypoxic Ischemic Encephalopathy and Neurological Pupil Index in Neonates
NCT06855108Phase 3Not Yet RecruitingPrimary
Caffeine for Hypoxic Ischemic Encephalopathy
NCT06694545Not Yet RecruitingPrimary
Neonates with Hypoxic Ischemic Encephalopathy (HIE)
Showing all 6 trials